Beractant is a pulmonary surfactant used for the treatment of Respiratory Distress Syndrome (RDS) in premature infants. Considered a natural source of surfactant as it is made from bovine lung extract, beractant contains a mixture of phospholipids, neutral lipids, fatty acids, and surfactant-associated proteins such as SP-B and SP-C. The final composition pr...
Beractant is indicated for prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants.
Zekai Tahir Burak Hospital, Ankara, Turkey
University of Vermont, Burlington, Vermont, United States
University of Miami, Miami, Florida, United States
Indiana University, Indianapolis, Indiana, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.